Cleared Traditional

K830005 - IP SPECIFIC G

K830005 is an FDA 510(k) clearance for IP SPECIFIC G, manufactured by Diagnostic Reagent Tech.. The device is a Class 2 Chemistry device with product code DAA cleared through the Traditional 510(k) pathway after a 150-day FDA review.

K830005 · Diagnostic Reagent Tech. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1983
Decision
150d
Days
Class 2
Risk

K830005 is an FDA 510(k) clearance for the IP SPECIFIC G. Classified as Igg, Peroxidase, Antigen, Antiserum, Control (product code DAA), Class II - Special Controls.

Submitted by Diagnostic Reagent Tech. (Mchenry, US). The FDA issued a Cleared decision on June 2, 1983 after a review of 150 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 866.5510 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Diagnostic Reagent Tech. devices

FDA 510(k) Submission Details - K830005

510(k) Number K830005 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 03, 1983
Decision Date June 02, 1983
Days to Decision 150 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
62d slower than avg
Panel avg: 88d · This submission: 150d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DAA Device Classification - Class 2, Special Controls

Product Code DAA Igg, Peroxidase, Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5510
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.